Daniel Anderson is an accomplished biotechnology leader with extensive experience in oncology and rare disease therapeutics. With a strong background in technology advancement and team building, Anderson has a demonstrated track record of moving programs towards the clinic, target discovery, and translational biology. He received his PhD in Cell Biology and Microscopy from UC San Diego and a BS in Biology from the University of Pittsburgh. Anderson has held senior leadership positions at various organizations, including Eikon Therapeutics and Recursion Pharmaceuticals. He has also worked as a researcher at prestigious institutions such as the Salk Institute, University of Pittsburgh, and University of Pennsylvania.